Position in CRBU
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,873,928
+$2,069,729 QoQ
Shares Held
1,632,914
+285.8% QoQ
Ownership
1.52%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 137 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in CRBU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $36,552,510,511 across 411 Biotechnology names. CRBU ranks #251 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,871,459 | $5,896,909,829 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,834,688 | $3,014,621,355 | |
| 3 | INCY |
Incyte Corp
|
9,722,336 | $1,102,124,008 | |
| 4 | MRNA |
Moderna, Inc.
|
15,726,193 | $1,101,305,295 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,555,689 | $1,070,369,059 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,897,051 | $917,119,711 | |
| 7 | RPRX |
Royalty Pharma plc
|
12,338,229 | $691,804,500 | |
| 8 | INSM |
INSMED Inc
|
6,052,174 | $645,282,791 |
All Filings in CRBU
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,873,928 | 1,632,914 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $804,199 | 423,263 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $672,988 | 423,263 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $899,992 | 386,263 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $451,285 | 358,163 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,498,398 | 1,641,181 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,635,521 | 1,657,561 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,171,756 | 1,618,243 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,649,549 | 1,615,579 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $32,625,229 | 6,347,321 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $29,335,686 | 5,119,666 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $25,589,199 | 5,353,389 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,548,120 | 1,070,146 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $17,816,600 | 3,355,292 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $20,089,048 | 3,198,893 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $25,272,208 | 2,395,470 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $4,330,968 | 797,600 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $6,820,941 | 743,022 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,231,385 | 412,948 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,769,269 | 283,589 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||